Cargando…
Is there a difference in testosterone levels and its regulators in men carrying BRCA mutations?
BACKGROUND: Male BRCA mutation carriers are at risk for an early onset aggressive prostate cancer. No data exist on the association of testosterone levels among these patients. We aimed to analyze testosterone and associated hormonal levels among male BRCA carriers and non-carriers. PATIENTS AND MET...
Autores principales: | Goldberg, Hanan, Grievink, Liat Shavit, Mano, Roy, Ber, Yaara, Ozalbo, Rachely, Tuval, Sivan, Baniel, Jack, Margel, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5732770/ https://www.ncbi.nlm.nih.gov/pubmed/29262604 http://dx.doi.org/10.18632/oncotarget.21802 |
Ejemplares similares
-
Vascular endothelium function among male carriers of BRCA 1&2 germline mutation
por: Witberg, Guy, et al.
Publicado: (2019) -
3,3-Diindolylmethane (DIM): a nutritional intervention and its impact on breast density in healthy BRCA carriers. A prospective clinical trial
por: Yerushalmi, Rinat, et al.
Publicado: (2020) -
A noninferiority within-person study comparing the accuracy of transperineal to transrectal MRI–US fusion biopsy for prostate-cancer detection
por: Ber, Yaara, et al.
Publicado: (2020) -
Personalized prostate cancer screening among men with high risk genetic predisposition- study protocol for a prospective cohort study
por: Margel, David, et al.
Publicado: (2014) -
Changes in Urology After the First Wave of the COVID-19 Pandemic
por: Margel, David, et al.
Publicado: (2021)